For many life sciences organizations, contract management remains a fragmented process involving scattered spreadsheets, disparate legacy systems, and disconnected email threads. These manual workflows often create significant hurdles in meeting stringent regulatory standards such as HIPAA, HITRUST, and FDA guidelines. By centralizing operations, companies aim to gain better visibility into their obligations and risk profiles.
The upcoming session, titled "Pharma Contracts Made Simple: Collaborate, Review, and Stay Compliant," focuses on practical applications of automated software. Attendees will see a demonstration of the Collaborative Online Document Editor, designed to synchronize legal, clinical, and compliance teams during the review process. The presentation also highlights the role of VISDOM® AI in identifying critical provisions and potential compliance risks automatically.
"Pharma, biotech, and life sciences organizations are hungry for a more centralized, visible, regulated, and automated solution for the contract challenges of the day," said Bradford Jones, Vice President of Sales & Marketing at CobbleStone Software. He noted that by leveraging AI-powered tools for authoring and negotiation, these teams can reduce administrative overhead and prioritize medical and scientific research.

Comments (0)
No comments yet. Be the first!